These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002818-11 Magnesium Sulphate for the Prevention of Super Ventricular Dysrrhythmias following Non-Cardiac Thoracic Surgery not-yet-due
Ongoing 2005-002327-13 Mild to moderate intermittent claudication: the clinical and cost-effectiveness of supervised exercise programmes and Cilostazol therapy in patient management not-yet-due
Not reported 2005-002782-37 A Randomised Trial of Inhaled Entonox Plus Local Anaesthesia Versus Intravenous Midazolam Plus Local Anaesthesia To Improve Pain Control During Bone Marrow Biopsy 2007-06-08 due-trials
Not reported Terminated 2005-004196-37 Taurine and Painful Diabetic Neuropathy 2014-08-21 due-trials
Ongoing 2005-004636-52 Randomised Double-Blind Placebo Controlled Trial of 40mg/day of Atorvastatin on Reduction in Severity of Sepsis in Ward Patients not-yet-due
Reported results Terminated 2006-002647-86 BALTI-2: Beta Agonists in Lung Injury Trial 2011-04-26 due-trials
Reported results 2006-005597-43 Topical Retinoids and Diabetic Neuropathic Ulceration 2013-07-03 due-trials
Not reported Terminated 2006-005630-21 The effect of Pregabalin on Pain progressing in Painful Diabetic Neuropathy 2014-05-19 due-trials
Not reported 2007-003327-21 Oral Contrast Agent for Elective Abdominopelvic CT: Water versus Dilute Gastrografin 2010-12-03 due-trials
Reported results 2007-004096-19 Beta Agonist Lung injury Trial - Prevention Study 2011-12-01 due-trials
Not reported 2011-002343-99 An Open-label Study into the Efficacy and Dosing of Probiotic Escherichia coli Nissle 1917 for Prevention of Gram-negative Gastric Colonisation in Ventilated Intensive Care Patients. 2014-06-13 due-trials
Not reported Terminated 2011-006049-14 Vildalgliptin and Glucose Variability in Type 2 Diabetes 2014-05-19 due-trials